Approval · Notice of Compliance 16802 · 2015
DOMPERIDONE: Notice of Compliance 16802
Issued April 15, 2015
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 16802
- Date
- April 15, 2015
- Company
- Sivem Pharmaceuticals UlcSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Update to the safety information in the product monograph
- Therapeutic class
- Modifier of upper gastroinestinal motility
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DOMPERIDONE | 02238341 | Marketed |
Medicinal ingredients
- DOMPERIDONE MALEATE 10 MG per MG